Replies to post #223604 on Innovation Pharmaceuticals Inc (IPIX)

[Cherry_11]

No one cares AM17. No one is trying to convince you to keep any shares. Well move on and save yourself some grief. Why waste time posting your negative outlook on the company. No facts just opinions you express.

IPIX will shine soon

[BonelessCat]

The post is specious and maybe a bit disingenuous with a rhetorical device about how many BPs showed interest the past 5 years. Well, 5 years ago the company was still a Phase 1 biopharma. At the time the CEO stated the best deals come after Phase 2 trials, and the very best deals occur at Phase 3.The company is now Phase 2/3 with one more trial report on the way. The company has only just entered what he said would be his strongest negotiating position with a 3rd drug on the cusp of the same. Anyone who has been here for 5 years should know all this, and in a fair argument and criticism would acknowledge that the CEO has been clear about his intentions to court BP only at this juncture. Just this past February he announced ~20 CDAs, which is in keeping with what he said 5 years ago about what would be the conditions for eventual licensing agreements.

We have seen how many companies are interested in last 5 years - talk is cheap - actions talk

[sox040713]

Way to tell us hindsight is 20/20 or Monday morning quarterback is easy.

I can also give you many examples of BPs invested too early and failed. The most recent example being J&J failed Antagonist’s preclinical IBD drug.

After Phase 2 and before Phase 3 is the sweet spot for both parties IMO. It reduces risk for the BP and increases value for the small biotech. That’s where B-OM is at.

I can give many many examples of how BP puts their money when they are interested.